We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$43.8B
AUM Growth
+$2.95B
Cap. Flow
+$2.92B
Cap. Flow %
6.68%
Top 10 Hldgs %
29.71%
Holding
2,321
New
255
Increased
1,689
Reduced
325
Closed
50

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$408M
2
NVDA icon
NVIDIA
NVDA
+$395M
3
MSFT icon
Microsoft
MSFT
+$382M
4
AMZN icon
Amazon
AMZN
+$253M
5
PLTR icon
Palantir
PLTR
+$148M

Sector Composition

Rank Sector Weight
1 Technology 32.42%
2 Consumer Discretionary 10.78%
3 Consumer Staples 10.15%
4 Industrials 10.05%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRAB icon
2126
Grab
GRAB
$13.5B
$72.8K ﹤0.01%
+15,421
New +$70.2K
LUNG icon
2127
Pulmonx
LUNG
$49.4M
$72.4K ﹤0.01%
+10,669
New +$70.3K
ADT icon
2128
ADT
ADT
$5.16B
$71.7K ﹤0.01%
10,376
-1,139
-10% -$8.3K
LZM icon
2129
Lifezone Metals
LZM
$291M
$71.5K ﹤0.01%
+10,285
New +$68.8K
DSGN icon
2130
Design Therapeutics
DSGN
$736M
$71.1K ﹤0.01%
+11,525
New +$66.7K
ACCD
2131
DELISTED
Accolade Inc
ACCD
$70.4K ﹤0.01%
20,574
+6,771
+49% +$24.1K
ALDX icon
2132
Aldeyra Therapeutics
ALDX
$91.7M
$70K ﹤0.01%
+14,031
New +$72K
HDSN
2133
Hudson Technologies
HDSN
$267M
$69.9K ﹤0.01%
+12,519
New +$82.5K
WOW
2134
DELISTED
WideOpenWest
WOW
$69.8K ﹤0.01%
+14,081
New +$72K
SRTA
2135
Strata Critical Medical Inc
SRTA
$436M
$69.5K ﹤0.01%
16,341
+5,377
+49% +$20.5K
BLZE icon
2136
Backblaze
BLZE
$697M
$67.7K ﹤0.01%
+11,241
New +$76.3K
OLPX
2137
DELISTED
Olaplex Holdings
OLPX
$67.6K ﹤0.01%
39,052
+12,852
+49% +$25.6K
BARK icon
2138
BARK
BARK
$74.8M
$67.3K ﹤0.01%
1,828
+576
+46% +$20.2K
AVAH icon
2139
Aveanna Healthcare
AVAH
$2.06B
$67.3K ﹤0.01%
+14,719
New +$75.4K
ILPT
2140
Industrial Logistics Properties Trust
ILPT
$613M
$67.1K ﹤0.01%
18,388
+6,051
+49% +$23.3K
RLGT icon
2141
Radiant Logistics
RLGT
$416M
$67K ﹤0.01%
+10,002
New +$68.9K
CTOS icon
2142
Custom Truck One Source
CTOS
$2.47B
$67K ﹤0.01%
+13,925
New +$63K
ASPI icon
2143
ASP Isotopes
ASPI
$487M
$66.8K ﹤0.01%
+14,751
New +$78.5K
AMPY icon
2144
Amplify Energy
AMPY
$163M
$66.3K ﹤0.01%
+11,043
New +$72.2K
MGNX icon
2145
MacroGenics
MGNX
$235M
$65.9K ﹤0.01%
20,284
+4,963
+32% +$17.9K
ORGO icon
2146
Organogenesis Holdings
ORGO
$308M
$65.1K ﹤0.01%
20,329
+6,689
+49% +$22.4K
OCGN icon
2147
Ocugen
OCGN
$410M
$64.9K ﹤0.01%
80,613
+32,262
+67% +$29.5K
PRME icon
2148
Prime Medicine
PRME
$533M
$64.8K ﹤0.01%
22,186
+4,375
+25% +$15.4K
BYND icon
2149
Beyond Meat
BYND
$288M
$63.3K ﹤0.01%
16,825
+5,537
+49% +$29.4K
DH icon
2150
Definitive Healthcare
DH
$72.1M
$61.7K ﹤0.01%
15,018
+4,943
+49% +$21.6K

Similar funds

ProShare Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, ProShare Advisors held 2,321 positions worth $43.8B, up 7.2% from $40.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

ProShare Advisors deployed $2.92B of net new capital in Q4 2024, opening 255 new positions and adding to 1,689 existing holdings. Its largest new stake was Applovin: 338,942 shares worth $110M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Walmart Inc, an estimated $285M trimmed.

  • ProShare Advisors's largest Q4 2024 buy was Applovin: 338,942 shares worth $110M.
  • ProShare Advisors added most to Apple in Q4 2024, an estimated $408M increase.
  • ProShare Advisors's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $285M.
  • ProShare Advisors fully exited PetIQ, Inc. Class A Common Stock in Q4 2024, selling an estimated $3.25M.
  • ProShare Advisors's ten largest holdings make up 30% of its $43.8B portfolio in Q4 2024.
  • ProShare Advisors opened 255 new positions and closed 50 in Q4 2024.
  • ProShare Advisors's portfolio value rose 7.2% quarter-over-quarter to $43.8B.

Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.